Product Description: VRC-01 is a fully human IgG1 antibody that targets envelope glycoprotein gp120 Protein. VRC-01 blocks viral entry by partially mimicking the interaction of the CD4 receptor with HIV-1 gp120 envelope glycoprotein. The isotype control for VRC-01 can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Applications: COVID-19-anti-virus
Formula: N/A
References: [1]Teh AY, et al. Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco. Plant Biotechnol J. 2014 Apr;12(3):300-11.
CAS Number: 1412901-55-3
Molecular Weight: N/A
Research Area: Infection
Target: HIV